In cancers with TRK fusions, such as certain types of pediatric cancers and rare adult cancers, the fusion proteins result in the expression of chimeric TRK proteins that continuously activate downstream signaling pathways, driving uncontrolled cell growth and survival [34]. The gene discussed is NTRK1; the disease is cancer.